BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26466100)

  • 1. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
    PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Flux dialyzer 2.6 m2 is promising for free light chains removal in high-flux hemodialysis and in hemodiafiltration.
    El-Sayed H; Abdelmohsen W; Abdelmegied S; Emara A; Sultan R; El-Sharkawy M
    Egypt J Immunol; 2022 Oct; 29(4):106-114. PubMed ID: 36206153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of High-Flux, Super High-Flux, Medium Cut-Off Hemodialysis and Online Hemodiafiltration on the Removal of Uremic Toxins.
    Belmouaz M; Goussard G; Joly F; Sibille A; Martin C; Betous T; Thierry A; Bauwens M; Bridoux F
    Blood Purif; 2023; 52(3):309-318. PubMed ID: 36215951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis.
    Hutchison CA; Bradwell AR; Cook M; Basnayake K; Basu S; Harding S; Hattersley J; Evans ND; Chappel MJ; Sampson P; Foggensteiner L; Adu D; Cockwell P
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):745-54. PubMed ID: 19339414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Most recently developed polyester polymer alloy dialyzer: A new medium cut-off membrane?
    Maduell F; Rodríguez-Espinosa D; Rodas LM; Gómez M; Arias-Guillén M; Fontseré N; Vera M; Del Carmen Salgado M; Rico N; Broseta JJ
    Artif Organs; 2024 Jul; 48(7):753-762. PubMed ID: 38404240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hemodiafiltration vs. high-flux hemodialysis on alpha 1-microglobulin level and dialysate albumin loss using a dialyzer surface area of 2.6 m².
    ElSayed H; Fathy M; Khedr A; Hussein HS; Elbraky A; ElSharkawy M
    Egypt J Immunol; 2023 Jul; 30(3):124-133. PubMed ID: 37440533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of the Clearum dialyzer.
    Maduell F; Broseta JJ; Rodríguez-Espinosa D; Hermida-Lama E; Cuadrado-Payán E; Rodas LM; Gómez M; Arias-Guillén M; Fontseré N; Vera M; Rico N
    Artif Organs; 2021 Oct; 45(10):1195-1201. PubMed ID: 33978975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high cut-off dialysis for acute kidney injury secondary to cast nephropathy in patients with multiple myeloma: a systematic review and meta-analysis.
    Tarragón B; Ye N; Gallagher M; Sen S; Portolés JM; Wang AY
    Clin Kidney J; 2021 Aug; 14(8):1894-1900. PubMed ID: 34345412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effect of high flux dialyzer surface area 2.6m2 in high flux hemodialysis and hemodiafiltration.
    ElSayed H; Mohamed A; Aref HM; Hussein HS; Gouda K
    Egypt J Immunol; 2024 Jan; 31(1):184-192. PubMed ID: 38225777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Expanded Hemodialysis with the Theranova 400 Dialyzer: A Randomized Controlled Trial.
    Weiner DE; Falzon L; Skoufos L; Bernardo A; Beck W; Xiao M; Tran H
    Clin J Am Soc Nephrol; 2020 Sep; 15(9):1310-1319. PubMed ID: 32843372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
    Bridoux F; Carron PL; Pegourie B; Alamartine E; Augeul-Meunier K; Karras A; Joly B; Peraldi MN; Arnulf B; Vigneau C; Lamy T; Wynckel A; Kolb B; Royer B; Rabot N; Benboubker L; Combe C; Jaccard A; Moulin B; Knebelmann B; Chevret S; Fermand JP;
    JAMA; 2017 Dec; 318(21):2099-2110. PubMed ID: 29209721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer.
    Maduell F; Broseta JJ; Rodríguez-Espinosa D; Del Risco-Zevallos J; Gómez M; Rodas LM; Arias-Guillén M; Vera M; Fontseré N; Salgado MDC; Rico N
    Blood Purif; 2023; 52(1):68-74. PubMed ID: 35551384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
    Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
    Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins.
    Kim YG; Lee SH; Jung SW; Jung GT; Lim HJ; Kim KP; Jo YI; Jin K; Moon JY
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 2 medium cutoff dialyzers versus on-line hemodiafiltration regarding depurative ability and albumin loss: An uncontrolled clinical research.
    Martínez-Miguel P; Gimena Muñoz R; Barrionuevo González M; López-Ongil S; Moro MÁ; Lizasoain I; Rodríguez-Puyol D; García Segura JM
    Artif Organs; 2023 Mar; 47(3):589-594. PubMed ID: 36420938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
    Steiner N; Abdel Hamid A; Kronbichler A; Neuwirt H; Myslivecek M; Kollar M; Lachmanova J; Rysava R; Hruskova Z; Spicka I; Willenbacher W; Nachbaur D; Wolf D; Tesar V; Gunsilius E
    J Nephrol; 2021 Aug; 34(4):1263-1270. PubMed ID: 33382447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hemodiafiltration superior to high-flow hemodialysis in reducing all-cause and cardiovascular mortality in kidney failure patients? A meta-analysis of randomized controlled trials.
    Bignardi PR; Delfino VDA
    Hemodial Int; 2024 Apr; 28(2):139-147. PubMed ID: 38369730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report.
    Donati G; Przygocka A; Zappulo F; Vischini G; Valente S; La Manna G
    BMC Nephrol; 2023 Jul; 24(1):204. PubMed ID: 37415110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the medium cutoff dialyzer and postdilution hemodiafiltration on the removal of small and middle molecule uremic toxins.
    Kim CS; Joo SY; Choi HS; Bae EH; Ma SK; Kim SW
    Kidney Res Clin Pract; 2023 Nov; 42(6):712-722. PubMed ID: 37448285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.